Theralink Technologies Inc

Theralink Technologies Inc. is a company based in Golden, Colorado, specializing in biotechnology research and development. With 13 employees, Theralink Technologies has over 16 years of experience in the field. Theralink Technologies offers a phosphoproteomic RPPA (reverse phase protein array) approach that quantifies the activation state of drug target proteins within tumor tissue. This technology serves as a decision support tool for physicians, aiding them in selecting therapies more likely to be effective. Their comprehensive panel of protein biomarkers targets a range of therapeutic molecular inhibitors, encompassing both FDA-approved medications and investigational drugs. Theralink Technologies differentiates itself through its unique phosphoproteomic approach, providing a more comprehensive understanding of drug-receptor and drug-protein interactions within tumors. For further information, you can visit their website at theralink.com.